Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

iDexis

23.07.2026

Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.

23.06.2026

iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.

02.06.2026

The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.

01.06.2026

Compounded GLP-1 injections are at the centre of a regulatory dispute. iDexis challenges SAHPRA and SAPC recall orders.

Search the archive

Browse by month